Venus Remedies R&D Unit Renewal from DSIR

Venus Remedies Limited's R&D unit, Venus Medicine Research Centre (VMRC), has successfully renewed its recognition from the Department of Scientific and Industrial Research (DSIR), Government of India. This renewal confirms VMRC's continued adherence to stringent criteria for in-house R&D, including qualified staff and dedicated research objectives. The recognition supports VMRC's ongoing projects, such as the development of VRP-034, a novel polymyxin formulation with USFDA QIDP designation, and the GASAR resistance surveillance study. This reaffirms the company's commitment to innovation in critical areas like antimicrobial resistance.